Artesunate reduces LPS-induced osteoclastogenesis by inhibiting the TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathways, thereby alleviating bone damage in RA (36). This evidence concerns the gene TLR4 and rheumatoid arthritis.